Current market cap 68mil Competitors market cap 115bil With almost half the shares on issue of CSL, while the top 20 hold 67% this is gonna fly is the deal goes through
On Friday, Sparling got good news, with the federal Health Department asking IDT to “conduct a feasibility assessment to assess the possibility of utilising the company’s sterile manufacturing facility to supplement the production capacity for a COVID-19 vaccine.”
The stock soared a staggering 44.6 per cent to 26.7¢.But even beyond the issue of vaccines, Sparling insists there is a bigger lesson for Australia from the pandemic about whether we should be so reliant on international supply chains for essential medicines.
He uses the analogy of products you would need if you were stuck on a desert island – antibiotics, anti-inflammatories and anaesthetics.First the covid vaccine then onto whats next, big bright future opening back up for IDT
